ClinicalTrials.Veeva

Menu

An RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral Reconstruction

N

Naval Military Medical University

Status

Completed

Conditions

Prostate Cancer
Urinary Incontinence

Treatments

Procedure: Standard RARP
Procedure: SFUR-RARP

Study type

Interventional

Funder types

Other

Identifiers

NCT04037800
CH-URO2019001

Details and patient eligibility

About

The study is a prospective randomized controlled trail to compare early urinary continence recovery after robotic-assisted radical prostatectomy with or without sustainable functional urethral reconstruction (SFUR).

Full description

Early urinary incontinence has always been a tricky problem for both patients and urologists, even though over 90% patients can recover 1 year after surgery. Many urologists are trying to modify the surgical technique to resolve this problem. Sustainable functional urethral reconstruction (SFUR) is a novel technique which may improve early urinary continence recovery for both local and locally advanced prostate cancer, and even for those with high volume prostate by providing adequate urethral length with bladder neck tubularization and making sustainable periurethral support with peritoneal flap. The purpose of this study is to verify the impact of this new technique on early recovery of urinary continence, as well as on urinary function and oncological outcomes.

Enrollment

96 patients

Sex

Male

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥40, but ≤75 years old;
  • Histological confirmed prostate cancer;
  • Localized or locally advanced prostate cancer;
  • Presence of urinary continence prior to the procedure;
  • Informed consent signed;

Exclusion criteria

  • Metastatic prostate cancer confirmed by ECT, PSMA or whole-body MRI;
  • Presence of any prostatic surgery(such as transurethral resection, laser therapy, microwave therapy, radiofrequency ablation and so on) prior to the procedure;
  • Radiation therapy of the prostate or pelvis prior to the procedure;
  • Uncontrolled intercurrent illness that would limit compliance with study requirements;
  • Any condition that contraindicates a radical prostatectomy;

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

96 participants in 2 patient groups

SFUR-RARP
Experimental group
Description:
Patients in which RARP with sustainable functional urethral reconstruction (SFUR) is performed.
Treatment:
Procedure: SFUR-RARP
Standard RARP
Active Comparator group
Description:
Patients in which standard RARP is performed.
Treatment:
Procedure: Standard RARP

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems